Nanochon Performs First Case in the Chondrograft™ First-in-Human Clinical Study


“The speed at which Dr. Osorio and the clinical team were able to identify, enroll, and treat the first patient underscores the significant unmet clinical need in cartilage repair,” said Ben Holmes, Co-Founder and Chief Executive Officer of Nanochon. “This milestone marks an important step forward for Nanochon as we continue generating the clinical evidence required to support a future Level 1 pivotal study.”



Source link

  • Related Posts

    “Stop the cuts at Bruyere Health:” CUPE to present worker-community petition to hospital management at rally on September 10

    Douglas Currier, the president of CUPE 4540, representing 875 staff at Bruyere, says these drastic measures take away from the goal of providing safe patient care. He said the PCA…

    Continue reading
    Some Navier-Stokes updates

    Some Terry Tao. More Terry Tao. Some ChatGPT. Some are calling this “a Deep Blue moment” for AI. All via T., a mathematician. The post Some Navier-Stokes updates appeared first…

    Continue reading

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    6 Rich-Looking Fall 2026 Color Trends From Zara

    6 Rich-Looking Fall 2026 Color Trends From Zara

    Richard Kelly on Donnie Darko at 25: ‘It’s a Miracle That Any Movie Gets Made’

    Richard Kelly on Donnie Darko at 25: ‘It’s a Miracle That Any Movie Gets Made’

    New Carnival Rewards Mastercard: Earn points and status

    New Carnival Rewards Mastercard: Earn points and status

    Valheim Review

    Valheim Review

    Announcement of new diplomatic appointment

    “Stop the cuts at Bruyere Health:” CUPE to present worker-community petition to hospital management at rally on September 10